Status:
UNKNOWN
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
Lead Sponsor:
Vielight Inc.
Conditions:
COVID-19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The objective of this study is to obtain data on the efficacy of the Vielight RX Plus in decreasing time to recovery of symptoms in subjects with COVID-19. The study will be conducted among COVID-19 p...
Detailed Description
This study is conducted entirely online. At no point will study staff be in direct contact with participants. The study will be managed by an independent clinical research organization (CRO), supporti...
Eligibility Criteria
Inclusion
- Confirmation of COVID-19 infection
- Experiencing moderate to severe respiratory symptoms
- Between 18-65 years of age
Exclusion
- Need for hospitalization at the time of diagnosis
- Current need for supplemental oxygen or positive pressure support and/or has required supplemental oxygen or positive pressure support for \>or= 24 hours
- \>10 days since symptom onset
- Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
- Pregnant
- Positive for Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) or Human Immunodeficiency Virus
- Inability to electronically complete study questionnaires in English
Key Trial Info
Start Date :
September 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
295 Patients enrolled
Trial Details
Trial ID
NCT04418505
Start Date
September 2 2020
End Date
September 30 2021
Last Update
June 14 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Progressive Medical Research
Port Orange, Florida, United States, 32127
2
Dr. Michael Zahavi
Oshawa, Ontario, Canada, L1H1G6